Doctors Using Cannabinoids and Terpenes for Patient Care - TrueMedX Bioceuticals

Doctors Using Cannabinoids and Terpenes for Patient Care

The use of cannabinoids and terpenes in patient care is gaining traction among healthcare providers due to their potential therapeutic benefits. These compounds, derived from the cannabis plant, interact with the body's endocannabinoid system (ECS) to help regulate various physiological processes. Hereā€™s a look at how doctors are integrating cannabinoids and terpenes into medical practice.

Cannabinoids in Patient Care

Cannabidiol (CBD)

  • Anxiety and Depression: CBD is widely used for its anxiolytic and antidepressant effects. Studies have shown that CBD can help reduce anxiety in patients with generalized anxiety disorder, social anxiety disorder, and post-traumatic stress disorder (PTSD) source.
  • Epilepsy: CBD has been approved by the FDA as a treatment for certain types of epilepsy, such as Dravet syndrome and Lennox-Gastaut syndrome, under the drug name Epidiolex source.
  • Chronic Pain: CBD is used to manage chronic pain conditions, including neuropathic pain and pain associated with multiple sclerosis (MS). Its anti-inflammatory properties help reduce pain without the psychoactive effects of THC source.

Tetrahydrocannabinol (THC)

  • Pain Management: THC is effective in treating pain, particularly in cancer patients and those with chronic pain conditions. It can modulate pain perception by interacting with CB1 receptors in the brain source.
  • Appetite Stimulation: THC is used to stimulate appetite in patients suffering from cachexia due to cancer or HIV/AIDS. It helps in maintaining body weight and improving overall nutritional intake source.
  • PTSD: Low doses of THC have been found to help in the extinction of traumatic memories, providing relief for PTSD patients source.

Minor Cannabinoids

  • Cannabigerol (CBG): CBG is being explored for its potential in treating inflammatory bowel disease, glaucoma, and neurodegenerative diseases. It has shown promise in preclinical studies for its anti-inflammatory and neuroprotective effects source.
  • Cannabinol (CBN): CBN is often used for its sedative properties, making it useful for patients with sleep disorders. It also has potential analgesic properties that can complement other cannabinoids source.

Terpenes in Patient Care

Limonene

  • Mood Enhancement: Limonene, found in citrus fruits, is known for its uplifting and mood-enhancing properties. It is used to reduce stress and improve mental clarity source.
  • Anti-Anxiety: Limonene has been shown to reduce anxiety and is often included in formulations aimed at promoting relaxation and mental well-being source.

Linalool

  • Sedation and Sleep: Linalool, found in lavender, has sedative properties that make it beneficial for patients with insomnia and other sleep disorders. It is also used for its calming effects on the nervous system source.
  • Pain Relief: Linalool's anti-inflammatory properties help in managing pain, particularly in conditions like arthritis and neuropathic pain source.

Beta-Caryophyllene

  • Anti-Inflammatory: Beta-caryophyllene, present in black pepper and cloves, binds to CB2 receptors and exerts potent anti-inflammatory effects. It is used to treat chronic pain and inflammatory conditions source.
  • Gastrointestinal Health: This terpene is beneficial for gastrointestinal health, helping to reduce inflammation and discomfort in conditions like irritable bowel syndrome (IBS) source.

The Entourage Effect

The entourage effect refers to the synergistic interaction between cannabinoids and terpenes, enhancing their therapeutic effects. By combining these compounds, doctors can tailor treatments to achieve more effective outcomes for various conditions. For instance, a combination of CBD and limonene might be used for anxiety, while THC and linalool could be used for sleep disorders.

Clinical Application and Patient Management

  1. Personalized Treatment Plans: Doctors are increasingly developing personalized treatment plans that consider the specific needs of each patient. This involves selecting the appropriate cannabinoids and terpenes based on the patientā€™s condition, symptoms, and response to treatment.
  2. Monitoring and Adjustment: Ongoing monitoring of patients is crucial to ensure the efficacy and safety of cannabinoid and terpene therapy. Doctors adjust dosages and combinations as needed to optimize therapeutic outcomes and minimize side effects.
  3. Education and Counseling: Educating patients about the potential benefits and risks of cannabinoids and terpenes is an essential part of the treatment process. Doctors provide guidance on usage, potential interactions with other medications, and lifestyle adjustments to enhance treatment efficacy.

Clinical Studies of Doctors Using Cannabinoids and Terpenes

The integration of cannabinoids and terpenes into clinical settings is becoming more prevalent as ongoing research highlights their potential therapeutic benefits. Here are some notable clinical studies and guidelines:

Clinical Trials

  1. UCSD Cannabis Clinical Trials:

    • Complex Regional Pain Syndrome (CRPS): A trial is investigating the effects and mechanisms of a high CBD cannabis extract on pain and health in CRPS patients. This study uses multiple psychophysical approaches and evaluates psychological and inflammatory markers to determine the efficacy of cannabinoids in pain management source.
    • HIV-Related Studies: Several trials are exploring how cannabinoids affect antiretroviral therapy pharmacokinetics, neurotoxicity, and cognitive functions in people with HIV. These studies aim to understand both the therapeutic benefits and potential adverse effects of cannabis use in this population.
  2. Chronic Pain Management:

    • BMJ Clinical Practice Guideline: This guideline provides a weak recommendation for the use of non-inhaled medical cannabis or cannabinoids as an adjunct to standard care for chronic pain management. The recommendation is based on systematic reviews indicating small improvements in pain intensity, physical functioning, and sleep quality, with an emphasis on shared decision-making due to the balance between benefits and risks source.

Key Findings and Applications

  • Pain Relief: Cannabinoids, particularly CBD and THC, are widely used for their analgesic properties. They are particularly beneficial in conditions like CRPS, chronic pain, and neuropathic pain, where conventional treatments may be insufficient.
  • Mental Health: CBD has been found effective in reducing anxiety and improving mood, which is crucial for patients with chronic illnesses or those undergoing treatments that affect mental health, such as HIV therapy source.
  • Anti-Inflammatory and Neuroprotective Effects: Cannabinoids and terpenes like beta-caryophyllene and limonene have shown significant anti-inflammatory and neuroprotective properties, making them valuable in treating conditions like MS and neuroinflammatory disorders source.

Methodologies in Clinical Studies

  • Psychophysical Approaches: These involve assessing the psychological and sensory responses to cannabinoid therapy, helping to understand their impact on pain perception and cognitive functions.
  • Biomarker Analysis: Studies often measure inflammatory markers and other biological indicators to determine the physiological effects of cannabinoids and terpenes.
  • Randomized Controlled Trials (RCTs): These are the gold standard in clinical research, providing robust data on the efficacy and safety of cannabinoid-based therapies.

Conclusion

The use of cannabinoids and terpenes in clinical settings is supported by a growing body of research. Clinical trials and guidelines are increasingly recognizing their potential, particularly for pain management, mental health, and inflammatory conditions. However, ongoing research is crucial to fully understand their benefits and risks, and to develop standardized protocols for their use in patient care.

_________________________________________________________________________

References:

Here are the cited sources from the blog "Doctors Using Cannabinoids and Terpenes for Patient Care":

1. CBD for Chronic Pain:
- Source: PubMed, highlighting CBD's anti-inflammatory properties for managing chronic pain, including neuropathic pain and multiple sclerosis. [PubMed](https://pubmed.ncbi.nlm.nih.gov)

2. THC for Pain Management and Appetite Stimulation:
- Source: NCBI, discussing THC's effectiveness in treating pain in cancer patients and those with chronic pain conditions, and its use for appetite stimulation in cachexia patients. Pain:Ā [NCBI](https://www.ncbi.nlm.nih.gov)Ā Appetite:Ā [NCBI](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791144/)

3. THC for PTSD:
- Source: NCBI, detailing how low doses of THC can help with traumatic memory extinction in PTSD patients. [NCBI](https://www.ncbi.nlm.nih.gov)

4. CBG and CBN for Various Conditions:
- Source: PubMed, discussing CBG's potential in treating inflammatory bowel disease, glaucoma, and neurodegenerative diseases.
- Source: NCBI, covering CBN's sedative properties and potential analgesic benefits for sleep disorders. CBG:Ā [PubMed](https://pubmed.ncbi.nlm.nih.gov)Ā CBN:Ā [NCBI](https://www.ncbi.nlm.nih.gov)

5. Limonene and Linalool for Anxiety and Sleep:
- Source: NCBI, highlighting limonene's mood-enhancing and anti-anxiety effects, and linalool's sedative properties for insomnia and pain management. Limonene: [NCBI]https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061257/) [NCBI](https://www.ncbi.nlm.nih.gov)

6. Beta-Caryophyllene for Anti-Inflammatory Effects:
- Source: PubMed, discussing beta-caryophyllene's anti-inflammatory effects and benefits for gastrointestinal health. [PubMed](https://pubmed.ncbi.nlm.nih.gov)

7. The Entourage Effect:
- Source: The Entourage Effect: Potential Synergy Between Cannabinoids and Terpenes:Ā (https://scholar.google.com/scholar?q=The+Entourage+Effect:+Potential+Synergy+Between+Cannabinoids+and+Terpenes&hl=en&as_sdt=0&as_vis=1&oi=scholart)

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.